Two Sigma Securities’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
ASN
CCP
NAM
RJA
WIA
Two Sigma Securities's SBIO Position: Q1 2019 in Review
Two Sigma Securities sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2019, closing a stake of 10,586 shares — an estimated $298K sold.
Two Sigma Securities first reported a position in SBIO in Q4 2018 and held it in 1 quarter. The position peaked at $298K in Q4 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2019.
- Two Sigma Securities reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2019 after selling out during the quarter.
- Two Sigma Securities sold 10,586 ALPS Medical Breakthroughs ETF shares in Q1 2019, an estimated $298K.
- Two Sigma Securities first reported a position in ALPS Medical Breakthroughs ETF in Q4 2018 and held it in 1 quarter.
- Two Sigma Securities's ALPS Medical Breakthroughs ETF position peaked at $298K in Q4 2018.
- 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2019.
Based on Two Sigma Securities's 13F filing for Q1 2019, filed 15 May 2019.